Antiapoptotic molecule Bcl-2 is essential for the anabolic activity of parathyroid hormone in bone

Annals of the New York Academy of Sciences

Volumn 1192, Issue , 2010, Pages 330-337

  Nagase, Yuichi ^a   Iwasawa, Mitsuyasu ^a   Akiyama, Toru ^a   Ogata, Naoshi ^a   Kadono, Yuho ^a   Nakamura, Masaki ^a   Oshima, Yasushi ^a   Yasui, Tetsuro ^a   Matsumoto, Takumi ^a   Masuda, Hironari ^a   Bouillet, Philippe ^b   Nakamura, Kozo ^a   Tanaka, Sakae ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Bcl 2; Mineralization; Osteoblast; PTH

Indexed keywords

BIM PROTEIN; PARATHYROID HORMONE; PROTEIN BCL 2;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; BIOSYNTHESIS; BONE; BONE MASS; CONFERENCE PAPER; CONTROLLED STUDY; MOUSE; NONHUMAN; OSTEOBLAST;

MUS;

EID: 77950682087     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.05209.x     Document Type: Conference Paper

References (23)

1. Karsenty, G. & E.F. Wagner. 2002. Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2: 389-406. (Pubitemid 34436569)
2. Harada, S. & G.A. Rodan. 2003. Control of osteoblast function and regulation of bone mass. Nature 423: 349-355. (Pubitemid 40852710)
3. Boyle,W.J.,W.S. Simonet & D.L. Lacey. 2003. Osteoclast differentiation and activation. Nature 423: 337-342.
4. Manolagas, S.C. 2000. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr. Rev. 21: 115-137.
5. Okahashi, N. et al. 1998. Caspases (interleukin-1betaconverting enzyme family proteases) are involved in the regulation of the survival of osteoclasts. Bone 23: 33-41. (Pubitemid 28327499)
6. Jilka, R.L. et al. 1998. Osteoblast programmed cell death (apoptosis): modulation by growth factors and cytokines. J. Bone Miner Res. 13: 793-802.
7. Akiyama, T. et al. 2003. Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim. EMBO J. 22: 6653-6664. (Pubitemid 38009611)
8. Jilka, R.L. et al. 2007. Quantifying osteoblast and osteocyte apoptosis: challenges and rewards. J. Bone Miner Res. 22: 1492-1501.
9. Tsujimoto, Y. et al. 1984. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 226: 1097-1099. (Pubitemid 15217831)
10. Tsujimoto, Y. et al. 1985. Involvement of the bcl-2 gene in human follicular lymphoma. Science 228: 1440-1443. (Pubitemid 15041322)
11. Kim, H. et al. 2006. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat. Cell Biol. 8: 1348-1358. (Pubitemid 44835109)
12. Veis, D.J. et al. 1993. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75: 229-240.
13. Nakayama, K. et al. 1994. Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc. Natl. Acad. Sci. USA 91: 3700-3704. (Pubitemid 2086624)
14. Nakayama, K. et al. 1993. Disappearance of the lymphoid system in Bcl-2 homozygousmutant chimeric mice. Science 261: 1584-1588. (Pubitemid 23319602)
15. Linette, G.P. et al. 1996. Cross talk between cell death and cell cycle progression: BCL-2 regulates NFATmediated activation. Proc.Natl. Acad. Sci.USA 93: 9545-9552.
16. Bouillet, P. et al. 2001. Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. Dev. Cell. 1: 645-653. (Pubitemid 33586117)
17. Amling,M. et al. 1997. Bcl-2 lies downstream of parathyroid hormone-related peptide in a signaling pathway that regulates chondrocyte maturation during skeletal development. J. Cell Biol. 136: 205-213.
18. Mocetti, P. et al. 2001. Bcl-2 and Bax expression in cartilage and bone cells after high-dose corticosterone treatment in rats. Tissue Cell. 33: 1-7.
19. Boot-Handford, R.P. et al. 1998. The bcl-2 knockout mouse exhibits marked changes in osteoblast phenotype and collagen deposition in bone as well as a mild growth plate phenotype. Int. J. Exp. Pathol. 79: 329-335.
20. Lagasse, E. & I.L. Weissman. 1997. Enforced expression of Bcl-2 inmonocytes rescuesmacrophages and partially reverses osteopetrosis in op/opmice. Cell 89: 1021-1031. (Pubitemid 127678736)
21. McGill, G.G. et al. 2002. Bcl2 regulation by the melanocyte master regulatorMitfmodulates lineage survival and melanoma cell viability. Cell 109: 707-718.
22. Ranger, A.M., B.A. Malynn & S.J. Korsmeyer. 2001. Mouse models of cell death. Nat. Genet. 28: 113-118.
23. Yamashita, J. et al. 2007. Role of Bcl2 in osteoclastogenesis and PTH anabolic actions in bone. J. Bone Miner Res.